Indication for treatment, prevention, or diagnosis
Mechanism of Action# Preclinical mechanism -- The following description is based on cell culture and animal studies
To date, no clinical trial has specifically evaluated BPC-157s potential to promote tumors or metastasis
We pride ourselves on our expertise, comprehensive wellness solutions, and our strong dedication to improving the health and well-being of every patient we serve
Mild Side Effects These side effects are reported anecdotally and tend to resolve on their own within a few days of use or dose adjustment: Headache or light-headedness Mild nausea or upset stomach (especially with oral use) Fatigue or lethargy in the first few days of use Appetite changes (increase or decrease) Injection site irritation redness, swelling, or tenderness Mild dizziness, nausea, and local irritation are among the most commonly reported side effects of subcutaneous BPC-157 injection, typically resolving within 2472 hours. Milekic, T
